Blog
12-16-2024Study Examined Tecovirimat in Countries Affected by Global Clade II Mpox Outbreak Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat did not…
Clinical Trials
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain - Blog
Help Scientists Find a Safe and Effective Mpox Treatment 05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can… - Blog
Clinical Trial Evaluating Monkeypox Vaccine Begins 09-09-2022Cross-posted from NIAID Newsroom NIH Trial is Evaluating Intradermal Delivery to Expand the Vaccine Supply. Interested volunteers can visit clinicaltrials.gov… - Blog
Happy Heart Month: What People Living with HIV Should Know 02-14-2018Happy Heart Month: What People Living with HIV Should KnowCross-posted from NIAID Now BlogToday marks not just a time to exchange valentines and chocolates,… - Blog
NIH and Partners Launch HIV Vaccine Efficacy Study 11-30-2017Cross-posted from NIH Newsroom, November 30, 2017 Public-Private Partnership Begins Clinical Trial in Sub-Saharan AfricaThe National Institutes of Health and… - Blog
Focusing the Science-Driven HIV Research Enterprise 09-21-2017Cross-posted from NIAID.Take a moment to imagine the future of the HIV pandemic, and how we as the research community can make that future better. Do you… - Blog
NIAID Supports Research Towards Healthy Aging for People Living with HIV 09-18-2017Cross-posted from NIAID Now BlogToday marks the 10th National HIV/AIDS and Aging Awareness Day. This annual observance brings attention to the unique social… - Blog
This February, Take Heart: NIH is Committed to Preventing HIV-Related Heart Attacks and Strokes 02-14-2017Antiretroviral therapy (ART) has transformed HIV infection from an almost-always fatal disease to what is now a manageable, chronic health condition. Today, a… - Blog
Historic HIV Vaccine Clinical Trial: Facebook Live with NIH’s Dr. Dieffenbach 12-02-2016In a Facebook Live interview from Cape Town, South Africa earlier this week, we heard from NIH’s Dr. Carl Dieffenbach about the exciting launch of HVTN 702, a… - Blog
NIH Statement on World AIDS Day 2016 12-01-2016This year, the world marked the 35th anniversary of the first published reports of what would come to be known as HIV/AIDS. This disease has wrought enormous… - Blog
Watch HIV Vaccine Trial Launch in South Africa Via Facebook Live! This Wednesday! 11-29-2016Director’s Note, Office of HIV/AIDS and Infectious Disease Policy, HHS:Scientific advances have given us the tools we need to end new HIV infections and save… - Blog
First New HIV Vaccine Efficacy Study in Seven Years Has Begun 11-28-2016South Africa Hosts Historic NIH-Supported Clinical Trial November 27, 2016The first HIV vaccine efficacy study to launch anywhere in seven years is now testing… - Blog
ICYMI – Advances in Research on HIV Prevention for Women 10-27-2016Last week, in a Facebook Live event we heard from NIH’s Dr. Carl Dieffenbach about some new developments in HIV prevention for women shared at the HIV Research… - Blog
REPRIEVE Trial To Host Second Twitter Chat, #HIVAgingChat 09-13-2016Thanks to advances in effective HIV treatment, people living with HIV have the potential to live a nearly normal lifespan. In addition, more people living with… - Blog
NIH’s Dr. Dieffenbach Shares Final Update from AIDS 2016 07-20-2016In his third and final update from the International AIDS Conference (AIDS 2016) in Durban, South Africa, NIH’s Dr. Carl Dieffenbach discussed highlights of… - Blog
HIV Vaccine Research: Update from NIH’s Dr. Dieffenbach from 2nd Day of AIDS 2016 07-19-2016As the second day of the International AIDS Conference (AIDS 2016) came to a close in Durban, South Africa, we caught up with Dr. Carl Dieffenbach again via… - Blog
NIH’s Dr. Dieffenbach Shares Perspectives from First Day of AIDS 2016 07-18-2016The 21st International AIDS Conference (AIDS 2016) opened in Durban, South Africa today. As we've done from other scientific conferences, we caught up with Dr… - Blog
Vaginal Ring May Cut HIV Infection Risk if Used Consistently 07-18-2016NIH Clinical Trial Will Clarify Relationship between Ring Adherence, HIV Infection RiskA new exploratory analysis of data from the ASPIRE study has found that… - Blog
NIH’s Dr. Carl Dieffenbach Shares Highlights as IAS 2015 Begins 07-21-2015After the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) got underway in Vancouver, Canada yesterday, July… - Blog
International Study Demonstrates Benefits of Early HIV Treatment 06-01-2015The question of when to initiate antiretroviral therapy (ART) during the course of HIV infection has been debated for years, yet a conclusive answer has…